SBIR/STTR Research Award

Hybrid Nanochannel Arrays for Single Molecule Linear Genome Analysis

Award identifier b53f2dacbbc9f5a29f85195f4291fbd23ef3efa928648a62a86cf085f9e2e41fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,816,510

Program and phase

SBIR · Phase II

Award year

2009

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
BIONANOMATRIX, INC.
Proposal award date
Not reported
Contract end date
Not reported
UEI
KZ2NHNP623C1
Solicitation number
PHS2009-2
Topic code
Not reported

Research abstract

DESCRIPTION (provided by applicant): Hybrid Nanochannel Arrays for Single Molecule Linear Genome Analysis Abstract The objective of this proposal is to develop a fully integrated nanofluidic device for single molecule analysis of long, linearized, native state genomic DNA. The project will result in a simple, disposable chip that will allow direct, fluorescent single molecule analysis of structural, CNV, haplotype and epigenomic variations at the single molecule level. The resulting commercial system will permit researchers and clinicians to directly visualize genomic variations from a few kilobases to megabases in length, from as little as a single cell to common bulk preparation methods, on common microscope imaging systems. Advances in technologies to analyze complex genomes have allowed for significant collection and analysis of a wide range of genetic data including gross structural variation, repetitive elements, genotypes, haplotypes and more generically, the DNA sequence. But current technologies suffer from relatively low sensitivity and specificity due to data generated from averaged heterogeneous bulk sample preparations or difficulties in standardizing and scaling up the analytical platform and biochemical protocols. The proposed hybrid micro/nanofluidic device will allow isolation, manipulation and direct imaging of single molecule features without significantly changing upstream biochemical process of the samples. Leveraging high quality mass micro/nanofabrication technology developed by the semiconductor industry, these devices could be made truly affordable to end users while allowing consistent and comparable results on a standardized format. Based upon phase I results, we will optimize a nearly universal, high resolution single molecule level DNA analysis device. The specific aims of phase II are to 1) develop fluorescent standards and sample buffer for evaluating device performance, 2)develop a simple, disposable chip cartridge that can be easily loaded by standard pipetting, 3) develop a modular joystick control system for manipulating the flow of DNA within the device while mounted on standard microscopy systems. Completion of this project will result in an integrated biochip device capable of providing statistically significant, single-molecule-level analysis of megabase DNA with sub-kilobase resolution. This technology could greatly enhance our ability to understand many different types of genetic variations and of genomic instabilities related to cancer and other genetic diseases with consistent and reproducible performance that will enable broad incorporation of single molecule analysis into diagnostic and medical genetics applications. PUBLIC HEALTH RELEVANCE: The development of an open architecture, single molecule, linear DNA analysis system will provide researchers and clinicians alike a new tool for genomic investigation, providing new insights into the complexity of human genetic disease and genome structure. The availability of an inexpensive, disposable nanodevice compatible with common microscopy systems will enable broad access to single molecule research of human genome variation, such as structural mapping, haplotyping and even copy number variation, as well as the characterization of overall genomic state. This will help expand the use of genomic analysis as a tool for understanding complex disorders and will help enable the realization of practical, cost effective personalized medicine.

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Research funding history

5 SBIR/STTR records share this UEI (2006–2009). Reported award amounts total $2,977,280. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.